IL22RA1 and metabolic disease: To assess the effects of intestinal IL-22RA1 signaling in mediating the onset of diet-induced obesity metabolic disorders, we placed Il22ra1fl/fl;Villin-cre mice on a long-term (16 weeks) HFD.